期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 57, 期 12, 页码 6389-6392出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01509-13
关键词
-
资金
- Ferrer International S.A. (Barcelona, Spain)
- Departament de Universitats, Recerca I Societat de la Informacio de la Generalitat d'Catalunya [2009-SGR1256]
- Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Spanish Network for Research in Infectious Diseases [REIPI RD12/0015]
- FIS [11/02024]
In vitro activity of ozenoxacin, a novel nonfluorinated topical (L. D. Saravolatz and J. Leggett, Clin. Infect. Dis. 37:1210-1215, 2003) quinolone, was compared with the activities of other quinolones against well-characterized quinolone-susceptible and quinolone-resistant Gram-positive bacteria. Ozenoxacin was 3-fold to 321-fold more active than other quinolones. Ozenoxacin could represent a first-in-class nonfluorinated quinolone for the topical treatment of a broad range of dermatological infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据